PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
August 27, 2012New England Journal of Medicine2,854 citationsOpen Access

Intraaortic Balloon Support for Myocardial Infarction with Cardiogenic Shock

View Full Paper
HTHölger ThieleUZUwe ZeymerFNFranz‐Josef Neumann

Key Points

  • The research aims to determine whether intraaortic balloon counterpulsation reduces 30-day mortality in patients with cardiogenic shock due to acute myocardial infarction.
  • Randomized trial with early revascularization strategy planned for participants.
  • Assessment of 30-day mortality outcomes.
  • Trial registered under NCT00491036.
  • No significant reduction in 30-day mortality was observed among patients receiving intraaortic balloon support.

Abstract

The use of intraaortic balloon counterpulsation did not significantly reduce 30-day mortality in patients with cardiogenic shock complicating acute myocardial infarction for whom an early revascularization strategy was planned. (Funded by the German Research Foundation and others; IABP-SHOCK II ClinicalTrials.gov number, NCT00491036.).

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Thiele et al. (2012) studied this question.

synapsesocial.com/papers/6991f2a87c87ae1942b28efchttps://doi.org/10.1056/nejmoa1208410
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Intra-Aortic Balloon Counterpulsation in Cardiogenic Shock1973 · 549 citations
  2. 2Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: Design and rationale of the Intraaortic Balloon Pump in Cardiogenic Shock II (IABP-SHOCK II) trial2012 · 161 citations
  3. 3Shock in acute myocardial infarction: the Cape Horn for trials?2010 · 199 citations
  4. 4Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: The prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome*2009 · 343 citations
  5. 5Management of acute myocardial infarction in patients presenting with persistent ST-segment elevation2008 · 2,315 citations